Lobby organisation
Moderna, Inc.
Business / industry · Health & pharma · HQ: United States · Transparency Register entry
As of 9 September 2026, Moderna, Inc. appears in 8 declared MEP meetings (8 different MEPs), most often with Socialists & Democrats.
In their own words
“Moderna is a biotechnology company focused on developing and commercialising medicines and vaccines based on messenger RNA (mRNA) technology across multiple therapeutic areas including infections diseases, oncology and rare disease. The company's mission is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 8 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2021–2025. Bar length is relative to its busiest year (3 in 2022).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 8 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 10 Sep 2025 | Tilly Metz | Critical Medicines Act |
| 16 Jan 2024 | Tomislav Sokol | Pharmaceutical legislation |
| 30 Oct 2023 | Laura Ballarín Cereza | Pharmaceutical Package (Directive) |
| 18 Oct 2023 | Tiemo Wölken | Pharma Revision - Directive (staff level) |
| 10 Nov 2022 | Dolors Montserrat | Lessons learned on impact of COVID-19 pandemic |
| 31 May 2022 | Kathleen van Brempt | The current situation of the pandemic and the mRNA technology |
| 20 Apr 2022 | Tomas Tobé | Global health / advance mRNA vaccines |
| 9 Sep 2021 | Bernd Lange | General exchange of view |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.